Psychedelic Stocks,Shroom News Mydecine Discovers Over 40 Potential Pharmacologically Active Novel Compounds in Mushrooms By Dennis Mutua June 09, 2021 Life Sciences company focusing on developing and commercializing innovative solutions for treating mental health conditions Mydecine Innovations Group. (NEO: MCO) (OTC: MYCOF) announced having discovered over 40 novel compounds in...
Psychedelic Stocks,Shroom News CannMart Applies For a Canada Psychedelics Dealer License By Dennis Mutua June 08, 2021 Canada based pharmaceutical medical practice company CannMart Inc. announced having submitted an application for controlled drugs and substances dealer’s license for future storage and distribution of controlled substances inclu...
Psychedelic Stocks,Shroom News Deepak Chopra Reveals His First Psychedelics Experience While in Medical School By Dennis Mutua June 07, 2021 Indian-American author and an advocate for mental health, Deepak Chopra, has revealed his first experience with psychedelics substances which happened while he was still in medical school back in 1965. In his first psychedelic ...
Psychedelic Stocks,Shroom News ME Resource Submits Initial Listing Statement With CSE in Coordination With Albert Labs By Dennis Mutua June 04, 2021 Resources company focused of acquisition and development of oil and gas properties ME Resource Corp. has submitted an initial listing statement with the Canadian Securities Exchange (CSE) in coordination with its reverse take-ov...
Psychedelic Stocks,Shroom News Cybin Unveils Sponsorship of Kernel Flow Study to Measure Ketamine’s Psychedelic Effect on Celebral Cortex Hemodynamics By Dennis Mutua June 03, 2021 Life sciences Company specializing on advancing psychedelic therapeutics Cybin Inc. (OTCMKTS: CLXPF) announced sponsorship of a Kernel flow study technology to determine Ketamine’s psychedelic effect on cerebral cortex hemodynam...
Psychedelic Stocks,Shroom News MYND Life Sciences Unveils Depression Biomarker Diagnostic Program By Dennis Mutua June 02, 2021 Leading psychedelic drug developing company focused on improving mental health MYND Life Sciences. (CSE: MYND) has announced having expanded its intellectual property portfolio majorly to diagnose and monitor the treatment pattern...
Psychedelic Stocks,Shroom News Senator Weiner Pushing for Decriminalization of Psychedelics By Dennis Mutua June 01, 2021 California State Senator Scott Wiener is yet again on the spotlight for pushing for the decriminalization of psychedelics. Senator Weiner caught the public eye in relation to psychedelics when he introduced a bill seeking to decri...
Psychedelic Stocks,Shroom News COMPASS Pathways Files For its Fourth Patent Application By Dennis Mutua May 31, 2021 Mental healthcare company focused on accelerating patient access to evidence-based innovation in mental health COMPASS Pathways PLC. (CMPS) announced having filed for its fourth provisional patent application with the United State...
